Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
2nd June 2020 | Michael Sardano | 1,483 | Payment by withholding | $3.05 | $4,523.15 |
2nd June 2020 | Javier Rampolla | 1,186 | Payment by withholding | $3.05 | $3,617.30 |
2nd June 2019 | Michael Sardano | 1,948 | Payment by withholding | $5.59 | $10,889.32 |
2nd June 2019 | Arthur Levine | 14,628 | Payment by withholding | $5.59 | $81,770.52 |
22nd March 2019 | Kalman Fishman | 173 | Open or private sale | $7.50 | $1,297.50 |
22nd March 2019 | Stephen Brad Cohen | 595 | Open or private sale | $7.50 | $4,462.50 |
22nd March 2019 | Richard Golin | 492 | Open or private sale | $7.50 | $3,690.00 |
21st March 2019 | Richard Golin | 509 | Open or private sale | $7.50 | $3,817.50 |
20th March 2019 | Richard Golin | 5,943 | Open or private sale | $7.56 | $44,929.08 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Sensus Healthcare's SRT-100 is a photon x-ray low energy superficial radiotherapy system. It provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions.